SCHEMBL7009082

SCHEMBL7009082

CCOC(=S)CCCc1ccc2cc(Cl)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
ALOX15 P16050 2/20 0.37
IGF1R P08069 1/20 0.36
OPRK1 P41145 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
MAOA P21397 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
MAOB P27338 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
FFAR1 O14842 2/20 0.34
MAPK1 P28482 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16596060 0.77 CYP4F2 (0.56) CYP1A2ALOX15NPC1RAB9ASMN1; SMN2
SCHEMBL7016499 0.77 SMN1; SMN2 (0.44) CYP1A2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL16596058 0.75 SMN1; SMN2 (0.43) CYP1A2ALOX15OPRK1NPC1RAB9A
SCHEMBL7009077 0.74 CYP1A2 (0.48) CYP1A2ALOX15IGF1RNPC1RAB9A
SCHEMBL11270924 0.74 ALDH1A1 (0.48) CYP1A2ALOX15SMN1; SMN2LMNACYP3A4
SCHEMBL7016529 0.72 FFAR1 (0.41) CYP1A2ALOX15IGF1RNPC1RAB9A
SCHEMBL16414559 0.72 IGF1R (0.46) CYP1A2ALOX15IGF1RSIGMAR1L3MBTL1
SCHEMBL16596057 0.71 ALOX15 (0.42) CYP1A2ALOX15OPRK1NPC1RAB9A
SCHEMBL16414552 0.71 IGF1R (0.49) CYP1A2ALOX15IGF1RLMNASIGMAR1
SCHEMBL11369773 0.70 NAMPT (0.44) NPC1LMNAMAPK1GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof SULT1E1, RRS1, SHH CYP1A2 908/4885ALOX15 1872/4885IGF1R 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.